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The intestinal inflammatory response of traveler’s diarrhea acquired in Goa, India, and
Guadalajara, Mexico, was studied. Fecal lactoferrin was found in stool samples in which entero-
aggregative Escherichia coli (EAEC), enterotoxigenic E. coli, or Salmonella or Shigella species
were isolated, with Shigella-positive cases showing the highest level. Samples from cases of Shigella-
associated diarrhea had the highest concentrations of fecal cytokines. Travelers to India who had
EAEC-associated diarrhea showed elevated levels of interleukin (IL)– 8 (median, 341.15 pg/
mL) and IL-1b (median, 749.90 pg/mL). Although 15 travelers to Mexico who had EAEC-associ-
ated diarrhea had a median concentration of 0 pg/mL for both IL-8 and IL-1b, 2 had high levels of
IL-8 (1853 and 11,786 pg/mL), and 5 showed elevated levels of IL-1b (1–1240 pg/mL). Samples
from patients in India who had pathogen-negative diarrhea or from patients in Mexico who
had asymptomatic EAEC infection were negative for cytokines. Bacterial pathogens causing
traveler’s diarrhea commonly produce intestinal inflammation, although a subset of patients
with EAEC-associated diarrhea fail to develop an inflammatory response.
A group of organisms referred to collectively as “diarrheo-
genic Escherichia coli” is a major worldwide cause of illness
in children and adults. In 1987, Nataro et al. [1] described a
unique type of E. coli found among children with diarrhea in
Santiago, Chile. These bacteria could be identified by their
unique adherence to HEp-2 cells. The adherence pattern was de-
scribed as aggregative. Although different patterns of attachment
were identified, only the strains that had an aggregative adher-
ence pattern were associated with diarrhea in these children.
Enteroaggregative E. coli (EAEC) are now defined as E. coli
that adhere to HEp-2 cells in an aggregative pattern and that
do not secrete heat-stable or heat-labile enterotoxins [2]. Since
first described, EAEC have become increasingly recognized as
a leading cause of persistent childhood diarrhea in developing
countries [1, 2]. EAEC have also been shown to cause diarrhea
in travelers [3, 4], to cause foodborne outbreaks [5], and to be
responsible for diarrhea in patients with AIDS [6] and in chil-
dren attending day care centers [7].
The pathogenicity of EAEC is not completely understood. In
one study of children, EAEC have been shown to produce fecal
lactoferrin, interleukin (IL)–8, and IL-1b, which are markers of
intestinal inflammation [8]. Whether EAEC regularly induce
these or other cytokines has not been shown. In addition, it has
not been shown whether these markers of inflammation become
elevated in travelers who develop acute diarrhea and whether
the cytokine inflammatory response relates to presence or ab-
sence of pathogen-specific diarrhea. Fecal lactoferrin, a marker
of intestinal inflammation, has recently been shown by our group
to be elevated in US adults with traveler’s diarrhea acquired in
Mexico and caused by EAEC [9]. Intestinal and systemic inflam-
mation, including cytokine production, have been studied in diar-
rhea due to other bacteria, such as Shigella species [10, 11]. To
see whether there were organism-specific patterns of inflammation
with commonly encountered bacterial pathogens, we looked at
intestinal markers of inflammation in adults with traveler’s diar-
rhea in 2 widely separated regions of the world [12, 13].
Patients and Methods
Patient population. Stool samples were collected from adult
European travelers with diarrhea that developed during visits to re-
sort hotels in Goa, India, between 1996 and 1998 [12]. Stool samples
were collected from US students who acquired diarrhea during short-
term stays in Guadalajara, Mexico, during the summers of 1999 and
2000 [13]. Diarrhea was defined for both populations as the passage
of>3 stools in 24 h, with at least 1 additional sign or symptom and
a duration of<72 h. The signs or symptoms included abdominal pain
or cramps, nausea, vomiting, fecal urgency, blood in stools, or in-
creased intestinal gas. At both sites, patients provided a diarrheal
stool sample for study. In Mexico, US students attending the same
classes as case patients but who did not have enteric symptoms pro-
vided stool samples as control samples.
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Stool analysis. Stool samples obtained from patients with diar-
rhea and from asymptomatic control subjects in Mexico were tested
in our laboratories in Goa and Guadalajara for enteric pathogens, in-
cluding enterotoxigenic E. coli (ETEC), EAEC, and Shigella, Salmo-
nella, Campylobacter, Aeromonas, Plesiomonas, Vibrio, Giardia,
Entamoeba, and Cryptosporidium species, by use of the same methods
published elsewhere [14]. Three to 5 E. coli colonies from each
subject were transported to Houston on peptone stabs for studies to
determine whether they were ETEC or EAEC. Heat-stable and heat-
labile enterotoxins of E. coli were detected with oligonucleotides
labeled by T4 polynucleotide kinase and [32P]-ATP [14]. EAEC
were tested by the HEp-2 adherence assay [1, 3]. Stool samples
were tested for lactoferrin by latex agglutination (Leuko-Test; Tech-
lab). For cytokine and lactoferrin studies, stool samples were stored
at270C until use. Aliquots of the original stool sample were diluted
in PBS containing 2.5mg/mL leupeptin, 11mg/mL aprotinin, and 0.5
mM 4-(2-aminoethyl)benzenesulfonyl fluoride (Sigma). After being
thoroughly mixed and centrifuged (10 min at 10,000 g), the super-
natants were tested, by ELISA, for the following cytokines: IL-8,
IL-6, interferon (IFN)–g, IL-1b, IL-1 receptor antagonist (IL-
1ra), and tumor necrosis factor (TNF)–a (Quantikine; R&D Sys-
tems). Stool lactoferrin and cytokine profiles were determined for
patients positive for ETEC, EAEC, and Salmonella and Shigella
species. Other enteric pathogens (e.g., miscellaneous bacteria and
parasites) identified in small numbers were not included in the
study. Only patients with single pathogens isolated from stool
samples were included. Patients who had diarrhea but for whom
no pathogen was identified (Goa) and asymptomatic persons for
whom no pathogen was identified (Guadalajara) were included in
the lactoferrin and cytokine studies as negative control subjects.
Statistical analysis. Fecal lactoferrin levels and cytokine con-
centrations were compared by the Kruskal-Wallis nonparametric
group comparison. Data were analyzed with SAS, version 8 (SAS
Institute).
Results
Fecal lactoferrin levels, graded as 0–4, were determined for
the various study samples (figure 1). US subjects in Mexico who
had asymptomatic EAEC infection, asymptomatic pathogen-
negative travelers to Mexico, and travelers to India who had
pathogen-negative diarrhea had median fecal lactoferrin levels
of 0. The highest median level of lactoferrin, at 2, was found
among travelers with Shigella-associated diarrhea acquired in
India. Differences between groups were significant (P¼ :0029).
Lactoferrin levels did not differ between patients with EAEC-
associated diarrhea in India and those in Mexico (P ¼ :593).
Fecal cytokine profiles were determined for patients with
pathogen-specific diarrhea acquired in India (table 1). This in-
cluded a study of cases of diarrhea due to EAEC (14 subjects),
ETEC (44 subjects), and Shigella (11 subjects) and Salmonella
(10 subjects) species. Cytokine results were compared with find-
ings in diarrheal stool samples from patients for whom an enteric
pathogen was not identified. Variations in the number of samples
tested for each cytokine were due to availability of specimens.
The median concentration of fecal IL-6 for diarrhea due to EAEC,
ETEC, and Salmonella species and for the pathogen-negative
control samples was 0 pg/mL. Diarrhea due to Shigella species
was associated with low levels of fecal IL-6 (9.64 pg/mL), which
was significant when compared with the other groups studied
(P ¼ :0001). When compared in a pairwise fashion, IL-6 pro-
duction in Shigella-associated diarrhea was not significantly
different from that of the other diarrhea groups (for Shigella
vs. ETEC, P ¼ :0825; vs. EAEC, P ¼ :0558; vs. Salmonella,
P ¼ :1555; and vs. no pathogen, P ¼ :1660).
The median concentration of fecal TNF-a for diarrhea due to
EAEC, ETEC, and Salmonella species and for the pathogen-
negative control samples was 0 pg/mL. Diarrhea due to Shigella
species was associated with a median TNF-a concentration of
2921.45 pg/mL, which was significant when compared with the
other groups studied (P ¼ :0001). When compared in a pairwise
fashion, production of TNF-a in Shigella-associated diarrhea
was statistically significantly different from that of the other
diarrhea groups and the control group (for Shigella vs. ETEC,
P ¼ :0001; vs. EAEC, P ¼ :0009; vs. Salmonella, P ¼ :0017;
and vs. no pathogen, P ¼ :0097).
The median concentration of fecal IFN-g for diarrhea due to
ETEC and Salmonella species and for the control samples was 0
pg/mL. Production of fecal IFN-g in patients with EAEC-associ-
ated diarrhea was 21.61 pg/mL. Diarrhea due to Shigella species
was associated with a median IFN-g concentration of 106.79 pg/
mL. These amounts were not significantly different compared
Figure 1. Fecal lactoferrin levels in adults with traveler’s diarrhea,
by pathogen and geographic location. Stool samples from control sub-
jects and patients were tested for lactoferrin by latex agglutination.
Groups tested included 10 travelers to Mexico who had asymptomatic
enteroaggregative Escherichia coli (EAEC) infection (EAM); 16 trav-
elers to Mexico who had EAEC-associated diarrhea (EDM); 14 travel-
ers to India who had EAEC-associated diarrhea (EDI); 44 travelers to
India who had enterotoxigenic E. coli–associated diarrhea (ETEC); 11
travelers to India who had Shigella-associated diarrhea (SHIG); 10 trav-
elers to India who had Salmonella-associated diarrhea (SALM); 13
asymptomatic travelers to Mexico for whom no pathogen was isolated
(NAM); and 9 travelers to India who had pathogen-negative diarrhea
(NDI). Agglutination was graded as follows: 0, no agglutination and
therefore no lactoferrin present; 4, maximum agglutination. Bars rep-
resent median levels. Differences among groups were statistically sig-
nificant (P ¼ :0029, Kruskal-Wallis test).
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with the other groups studied (P¼ :0871). When compared in a
pairwise fashion, concentrations of IFN-g were not statistically
significantly different in any of the diarrhea groups or in the con-
trol group (for EAEC vs. ETEC, P ¼ :4092; Shigella vs. ETEC,
P ¼ :1290; Salmonella vs. ETEC, P ¼ :7350; no pathogen vs.
ETEC, P ¼ :3289; EAEC vs. Shigella, P ¼ :3845; EAEC vs.
Salmonella, P ¼ :5258; EAEC vs. no pathogen, P ¼ :1163;
Shigella vs. Salmonella, P ¼ :1607; Shigella vs. no pathogen,
P ¼ :0594; and Salmonella vs. no pathogen, P ¼ :7080).
The median concentration of fecal IL-8 for the control sam-
ples from the 9 subjects with pathogen-negative diarrhea was
0 pg/mL. IL-8 was found in samples from all pathogen-specific
diarrhea groups, and the median concentrations (table 1) were sig-
nificant when compared together as a group (P ¼ :0001). When
compared in a pairwise fashion, IL-8 production in Shigella-
associated diarrhea was statistically significantly different from
that of the other diarrhea groups and the control group. In addi-
tion, compared with that in control subjects with pathogen-neg-
ative diarrhea, IL-8 production in patients with diarrhea due to
ETEC (P ¼ :0033) or EAEC (P ¼ :0269) was significant.
The median concentration of fecal IL-1b for the control samples
from the subjects with pathogen-negative diarrhea was 0 pg/mL.
Samples from the subjects with pathogen-specific diarrhea
showed elevated IL-1b, compared with control samples (table 1).
When compared in a pairwise fashion, only IL-1b production
in patients with Shigella-associated diarrhea was statistically
significantly different from that of the other diarrhea groups
and the control group (for Shigella vs. ETEC, P ¼ :0032; vs.
EAEC, P ¼ :0486; vs. Salmonella, P ¼ :0034; and vs. no path-
ogen, P ¼ :0018); group comparison showed statistical dif-
ferences as well (P ¼ :0304).
IL-1ra was found in samples from all groups studied, includ-
ing the pathogen-negative control subjects with diarrhea (table
1). When compared in a pairwise fashion, IL-1ra production in
Shigella-associated diarrhea was statistically significantly dif-
ferent from that of the other diarrhea groups and the control
group (for Shigella vs. ETEC, P ¼ :0001; vs. EAEC, P ¼ :0267;
vs. Salmonella, P ¼ :0001; and vs. no pathogen, P ¼ :0001). In
addition, IL-1ra production in Salmonella-associated diarrhea
was significantly different from that in the pathogen-negative con-
trol group (P ¼ :0015). IL-1ra production in EAEC-associated
diarrhea was significantly different from that in Salmonella-
associated diarrhea as well (P ¼ :0343). Group comparison
showed statistical significance (P ¼ :0001). The ratio of IL-1b
to IL-1ra also showed statistical significance (P ¼ :0001). The
IL-1b:IL-1ra ratios are given in table 1.
Fecal cytokine levels were tested for subjects traveling to
Mexico. The median concentrations of fecal IL-6, TNF-a, and
IFN-g were 0 pg/mL for all groups studied. Samples from trav-
elers to Mexico who had EAEC infection had median concen-
trations of 0 pg/mL for fecal IL-6, IL-8, TNF-a, IFN-g, and IL-
1b regardless of whether the subjects had diarrhea. Samples
from the asymptomatic pathogen-negative control subjects had
median concentrations of 0 pg/mL for the same fecal cytokines.
The median IL-1ra concentration was 99.49 pg/mL in stool
samples from travelers to Mexico with asymptomatic EAEC in-
fection, 156.34 pg/mL in stool samples from travelers to Mexico
who had EAEC-associated diarrhea, and 53.65 pg/mL in samples
from asymptomatic pathogen-negative travelers to Mexico.
Fecal IL-8 concentrations among the various groups (India or
Mexico) with EAEC infection are shown in figure 2. Samples
from travelers to Mexico who had asymptomatic EAEC infec-
tion, asymptomatic pathogen-negative subjects in Mexico, and
pathogen-negative patients with diarrhea in India had median
IL-8 concentrations of 0 pg/mL. IL-8 was not detected in indi-
vidual samples from the latter 2 groups; however, among trav-
elers to Mexico who had EAEC-associated diarrhea, 2 patients
were positive for IL-8, with concentrations of 1853 pg/mL
and 11,786 pg/mL, which represented the highest IL-8 concen-
tration in the study. Samples from travelers to India who had
EAEC-associated diarrhea had a median concentration of 341.15
pg/mL. Concentrations of IL-8 ranged from 0 to .4000 pg/
mL, with the highest levels found in patients with EAEC-associ-
ated diarrhea.
Fecal IL-1b concentrations in the various subject groups are
shown in figure 3. Samples from asymptomatic travelers to
Table 1. Fecal cytokines identified in samples from travelers with bacterial diarrhea acquired in Goa, India, 1996–1998.
Cytokine
EAEC ETEC Shigella Salmonella
No pathogen identified
(control samples)
P
No. of
samples
tested
Median
concentration,
pg/mL
No. of
samples
tested
Median
concentration,
pg/mL
No. of
samples
tested
Median
concentration,
pg/mL
No. of
samples
tested
Median
concentration,
pg/mL
No. of
samples
tested
Median
concentration,
pg/mL
IL-6 13 0 44 0 11 9.64 8 0 9 0 .0001
IL-8 14 341.15 43 315.16 11 3605.61 9 173.51 9 0 .0001
TNF-a 13 0 44 0 11 2921.45 10 0 9 0 .0001
IFN-g 6 21.61 23 0 9 106.79 5 0 9 0 .0871
IL-1b 14 749.90 43 97.91 11 792.96 9 35.39 9 0 .0304
IL-1ra 11 7161.05 41 1513.99 10 7645.48 6 291.38 9 218.68 .0001
IL-1b:IL-1ra 11 0.099 41 0.10 10 0.10 6 0.01 9 0 .0001
NOTE. Variations in no. of samples tested were due to availability of specimens. EAEC, enteroaggregative Escherichia coli; ETEC, enterotoxigenic E. coli;
IFN, interferon; IL, interleukin; IL-1ra, interleukin-1 receptor antagonist; TNF, tumor necrosis factor.
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Mexico who had EAEC infection had a median fecal IL-1b con-
centration of 0 pg/mL, with 1 sample producing 1180 pg/mL.
Samples from US travelers to Mexico who did not have diarrhea
or enteric pathogens had a median concentration of 0 pg/mL,
with 3 stool samples producing 2–90 pg/mL. Samples from trav-
elers to India who had pathogen-negative diarrhea had a median
concentration of 0 pg/mL, with 5 samples producing 60–1270
pg/mL. Samples from travelers to Mexico who had EAEC-
associated diarrhea had a median concentration of 0 pg/mL, with
5 samples producing 1–1240 pg/mL. Samples from travelers to
India who had EAEC-associated diarrhea had a median concen-
tration of 749.90 pg/mL (range, 0 to .800 pg/mL). The 2 pa-
tients in Mexico who had EAEC-associated diarrhea and the
highest levels of IL-8 (1853 and 11,786 pg/mL) also showed
high levels of fecal IL-1b (1183 and 1110 pg/mL, respectively)
and maximum (3) levels of lactoferrin.
Discussion
In a published study of patients with shigellosis, immunohis-
tochemical staining of rectal biopsy samples was done to look
for elevated concentrations of multiple cytokines. Increases in
levels of IL-1, IL-6, IFN-g, and TNF-a were seen in samples
that had severe inflammation histologically [10]. Another study
showed that infection with Shigella was associated with the re-
lease of a number of cytokines in the plasma and stool, including
TNF-a, IL-1b, IL-1ra, IL-6, IL-8, and IFN-g [11]. In the present
study, we examined these cytokines in patients with traveler’s
diarrhea. Previous studies have shown that fecal lactoferrin is
a sensitive marker for intestinal inflammation [15]. We have
shown a correlation between EAEC infection and elevated levels
of fecal lactoferrin but not elevated levels of fecal leukocytes
or frequency of stool samples testing positive by Hemoccult
[9]. In this study, we looked at fecal lactoferrin levels in the var-
ious study groups to determine the relationship between this
marker of intestinal inflammation and fecal levels of cytokines.
We were particularly interested in patients with EAEC infection
and diarrhea, to further our understanding of the pathogenicity
of this pathogen.
In the present study, symptomatic Shigella infection was
associated with the most intense response in bacterial diarrhea,
when we looked at the associated fecal lactoferrin and cytokine
levels. IL-6, TNF-a, and IFN-g levels were not found to be ele-
vated in samples from non–Shigella-associated diarrhea caused
by ETEC, Salmonella, or EAEC. Elevated levels of fecal IL-8
and IL-1b were found in samples from European travelers to
Goa, India, with symptomatic bacterial infection. EAEC-associ-
ated diarrhea occurring in India was associated with increased
fecal levels of IL-8, IL-1b, and IL-1ra, as was seen for travelers
to India who had ETEC diarrhea, shigellosis, or salmonellosis.
Samples from subjects with pathogen-negative diarrhea in India
were negative for these inflammatory products, showing an im-
portant relationship between intestinal inflammation and diarrhea
due to defined bacterial pathogens in this group of travelers. A
specific pattern of cytokine activation may distinguish specific
enteric infection, producing a pathogen signature. Future study
of the cytokine response of organism-specific infection is needed.
Of interest, a majority of the US students with diarrhea acquired
in Mexico were negative for inflammatory markers, even when
infected with EAEC strains.
This study demonstrated that diarrhea in international trav-
elers with EAEC infection may or may not be associated with
Figure 3. Fecal interleukin (IL)–1b levels in adult travelers to
Goa, India, and Guadalajara, Mexico, who had enteroaggregative Es-
cherichia coli (EAEC) infection. Groups tested included 10 travelers
to Mexico who had asymptomatic EAEC infection (EAM); 16 travelers
to Mexico who had EAEC-associated diarrhea (EDM); 14 travelers to
India who had EAEC-associated diarrhea (EDI); 13 asymptomatic trav-
elers to Mexico for whom no pathogen was isolated (NAM); and 9
travelers to India who had pathogen-negative diarrhea (NDI). Sym-
bols represent individual samples; horizontal lines represent median
concentrations. Differences among groups were statistically signifi-
cant (P ¼ :0098, Kruskal-Wallis test).
Figure 2. Fecal interleukin (IL)–8 levels in adult travelers to Goa,
India, and Guadalajara, Mexico, who had enteroaggregative Escheri-
chia coli (EAEC) infection. Groups tested included 9 travelers to
Mexico who had asymptomatic EAEC infection (EAM); 15 travelers
to Mexico who had EAEC-associated diarrhea (EDM); 14 travelers to
India who had EAEC-associated diarrhea (EDI); 11 asymptomatic trav-
elers to Mexico for whom no pathogen was isolated (NAM); and 9
travelers to India who had pathogen-negative diarrhea (NDI). Sym-
bols represent individual samples; horizontal lines represent median
concentrations. Differences among groups were statistically signifi-
cant (P ¼ :003, Kruskal-Wallis test).
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intestinal release of markers of inflammation. Steiner et al. [8]
previously showed that fecal IL-8, IL-1b, and lactoferrin could
be identified in samples from Brazilian children infected with
EAEC. Our data from a study of travelers to India who had
EAEC-associated diarrhea resembles findings for those Bra-
zilian children. In the study by Nataro et al. [1], patients with
EAEC infection had higher ratios of IL-1b to IL-1ra than did
uninfected control subjects. This presumably represents more
IL-1 receptor activation in these patients.
One possible explanation for variation in intestinal markers
of inflammation with EAEC-associated diarrhea is that not all
strains are pathogenic. Variation in virulence of EAEC has been
demonstrated in healthy volunteers given different strains [16].
Varying levels of virulence have also been shown in Nigerian
children with EAEC infection [17]. In the present study, there
were apparent differences in fecal lactoferrin concentrations
and cytokine production between most of the travelers to India
who had EAEC-associated diarrhea and a majority of the trav-
elers to Mexico who had EAEC-associated diarrhea. A number
of plasmid-encoded virulence factors have been recently identified
that appear to at least partially explain the pathogenic potential
of EAEC strains. These include the fimbriae AAF/I and AAF/
II, which are thought to play a role in mucosal adherence [18];
Pet (plasmid-encoded toxin) [19, 20]; EAST-1 (heat-stable en-
terotoxin) [21]; Shet1 and Shet2 (Shigella enterotoxins) [22];
AspU, which is a cryptic secreted protein [23]; and fliC, which
is thought to trigger IL-8 release [24]. We currently are examining
the EAEC strains isolated from travelers to India and Mexico, to
determine whether the presence or absence of defined virulence
properties correlates with different levels of inflammation, as test-
ed by fecal cytokine analysis. Host factors may be important in
the pathogenesis of EAEC-associated diarrhea. Children from
developing countries, where malnutrition is common, show a
more intense cytokine response and develop growth and devel-
opmental abnormalities associated with EAEC infection [8].
The major difference between our 2 study populations was country
of origin (i.e., Europe vs. the United States). The illness severity
in the 2 populations was comparable.
Differences in markers of inflammation between patients stud-
ied in India and those studied in Mexico could be explained by
geographic variations in organism virulence. Despite the differ-
ences in median concentrations of inflammatory markers in the
2 settings, individual patients in Mexico who had EAEC infec-
tion had inflammatory diarrhea: 2 of 15 patients with EAEC-
associated diarrhea from Mexico produced IL-8 (including the
subject with the highest concentration in either setting), and 5
of 16 patients produced detectable levels of IL-1b. Of note,
the 2 patients who produced IL-8 also produced large amounts
of IL-1b. The production of IL-8 also seemed to be related to
the production of lactoferrin. The 2 patients from Mexico who
had EAEC-associated diarrhea with increased fecal IL-8 pro-
duced 3 levels of lactoferrin, which were the highest recorded.
Asymptomatic EAEC infection is extremely common in US
travelers to Mexico [13], and EAEC strains commonly can be
found in foods served at public restaurants in this setting [25].
The common occurrence of asymptomatic EAEC infection in
travelers to Mexico and the lack of intestinal inflammatory mar-
kers raise questions about pathogenicity in these cases. Another
way to approach determination of the pathogenic potential of a
bacterial isolate in enteric infection is through documentation
of the intestinal secretory IgA (sIgA) response to the organism.
We have previously shown that virulent organisms induce a spe-
cific sIgA response during infection, whereas less pathogenic
strains do not [26]. We plan to study the sIgA response to ho-
mologous EAEC infecting the patients with cytokine-positive
and cytokine-negative diarrhea, to indirectly evaluate virulence
of the organism. We have previously found in a small study that
approximately one-half of patients with EAEC-associated diar-
rhea developed an sIgA response to their infecting organism
[27]. We believe that, through characterization of fecal cyto-
kines, EAEC virulence properties, and sIgA responses to in-
fecting strains, we will further our understanding of the patho-
genesis of EAEC-associated diarrhea.
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